Gastrointestinal Malignancies in 2019
and Beyond
The latest translational and therapeutic developments in GI cancer pathogenesis and treatment, and implications on individualized clinical decision-making. How will emerging research affect ongoing clinical trials, development of new compounds, and future treatment paradigms?
Faculty Chair
Howard Hochster, MD, FACP
Rutgers Cancer Institute, New Brunswick, NJ, USA
Look Inside This Report
Download a sample of this report and start discovering the insights
Topics Covered
-
- Metastatic Colorectal Cancer – Recent Insights and Future Approaches
- Immune and Targeted Therapies
- Chemotherapy and Radiation
- Gastroesophageal Cancers
- Hepatocellular and Biliary Tract Cancers
- Biology-Guided Treatment of Locally Advanced/Metastatic Pancreatic Cancer
- Strategic Recommendations
Faculty Members
Dirk Arnold, MD, PhD
University of Hamburg and Asklepios Tumor Center
Hamburg, Germany
Daniel Catenacci, MD
University of Chicago
Chicago, IL, USA
Michel Ducreux, MD, PhD
Institut Gustave Roussy
Villejuif, France
Axel Grothey, MD
West Cancer Center
Germantown, TN, USA
Scott Kopetz, MD, PhD
MD Anderson Cancer Center
Houston, TX, USA
Fotios Loupakis, MD, PhD
Veneto Institute of Oncology
Padua, Italy
Philip A. Philip, MD, PhD
Barbara Ann Karmanos Cancer Institute
Detroit, MI, USA
